Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,975 | 9 | 63.0% |
| Food and Beverage | $8,450 | 558 | 35.6% |
| Travel and Lodging | $226.46 | 1 | 1.0% |
| Education | $112.23 | 3 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $11,793 | 81 | $0 (2024) |
| PFIZER INC. | $5,548 | 65 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $842.65 | 27 | $0 (2024) |
| Novo Nordisk Inc | $672.47 | 45 | $0 (2024) |
| Lilly USA, LLC | $552.08 | 52 | $0 (2024) |
| Amgen Inc. | $452.59 | 29 | $0 (2024) |
| GlaxoSmithKline, LLC. | $392.53 | 29 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $359.64 | 22 | $0 (2023) |
| Astellas Pharma US Inc | $330.89 | 15 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $305.05 | 43 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,374 | 100 | ABBVIE INC. ($11,063) |
| 2023 | $1,414 | 94 | ABBVIE INC. ($372.71) |
| 2022 | $1,097 | 68 | GlaxoSmithKline, LLC. ($138.18) |
| 2021 | $816.90 | 56 | AbbVie Inc. ($244.19) |
| 2020 | $4,157 | 41 | PFIZER INC. ($3,679) |
| 2019 | $2,274 | 77 | PFIZER INC. ($1,477) |
| 2018 | $802.72 | 72 | PFIZER INC. ($164.34) |
| 2017 | $828.04 | 63 | AstraZeneca Pharmaceuticals LP ($147.89) |
All Payment Transactions
571 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,875.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.81 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.26 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $10.30 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: UROLOGY | ||||||
| 10/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Diabetes Care | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: VACCINES | ||||||
| 10/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Obesity | ||||||
| 09/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 666 | 892 | $157,289 | $38,747 |
| 2022 | 15 | 686 | 930 | $149,456 | $39,442 |
| 2021 | 13 | 669 | 932 | $132,125 | $51,498 |
| 2020 | 11 | 638 | 860 | $121,398 | $43,687 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 206 | 406 | $73,080 | $17,292 | 23.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 57 | 60 | $6,600 | $4,152 | 62.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 101 | $13,635 | $3,940 | 28.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $6,300 | $3,102 | 49.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 62 | 66 | $2,508 | $1,830 | 73.0% |
| 87637 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | Office | 2023 | 14 | 14 | $4,998 | $1,817 | 36.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 107 | 107 | $29,425 | $1,476 | 5.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 28 | 32 | $11,040 | $1,457 | 13.2% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 11 | 11 | $3,179 | $1,413 | 44.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 27 | 28 | $3,080 | $842.52 | 27.4% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 14 | 14 | $1,260 | $533.68 | 42.4% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 11 | 11 | $990.00 | $419.32 | 42.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $456.00 | $343.20 | 75.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 18 | 18 | $738.00 | $129.48 | 17.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 178 | 386 | $68,381 | $15,688 | 22.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 23 | 23 | $11,961 | $6,412 | 53.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 66 | 67 | $7,370 | $4,520 | 61.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 90 | $11,718 | $3,602 | 30.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 71 | 72 | $2,736 | $1,940 | 70.9% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 21 | 22 | $7,550 | $1,316 | 17.4% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 29 | 30 | $2,700 | $1,006 | 37.2% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 27 | 27 | $2,430 | $962.28 | 39.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 96 | 96 | $26,226 | $906.31 | 3.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 26 | 26 | $988.00 | $703.77 | 71.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 18 | 20 | $2,200 | $694.54 | 31.6% |
About Bradley Gray
Bradley Gray is a Family Medicine healthcare provider based in Florence, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/16/2009. The National Provider Identifier (NPI) number assigned to this provider is 1073752010.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Bradley Gray has received a total of $23,764 in payments from pharmaceutical and medical device companies, with $12,374 received in 2024. These payments were reported across 571 transactions from 48 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($14,975).
As a Medicare-enrolled provider, Gray has provided services to 2,659 Medicare beneficiaries, totaling 3,614 services with total Medicare billing of $173,375. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Florence, KY
- Active Since 02/16/2009
- Last Updated 09/07/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1073752010
Products in Payments
- UBRELVY (Drug) $6,047
- COLOGUARD (Device) $5,007
- QULIPTA (Drug) $4,921
- VRAYLAR (Drug) $848.22
- FARXIGA (Drug) $552.03
- MOUNJARO (Drug) $341.64
- JARDIANCE (Drug) $286.46
- TROKENDI XR (Drug) $279.78
- Aimovig (Biological) $222.64
- ENTRESTO (Drug) $206.26
- NURTEC ODT (Drug) $166.91
- TRELEGY ELLIPTA (Drug) $163.10
- Ozempic (Drug) $155.28
- REXULTI (Drug) $145.91
- LYRICA (Drug) $131.91
- GEMTESA (Drug) $130.41
- CHANTIX (Drug) $129.46
- FREESTYLE LIBRE 2 (Device) $124.80
- SHINGRIX (Biological) $123.42
- FREESTYLE LIBRE 3 (Device) $121.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Florence
Cory Smith, Md, MD
Family Medicine — Payments: $16,619
Donald Behling, Md, MD
Family Medicine — Payments: $16,401
Clarence Alexander, Md, MD
Family Medicine — Payments: $15,630
Dr. Guy Mcclary, Md, MD
Family Medicine — Payments: $15,201
Dr. Edward Schumann, Md, MD
Family Medicine — Payments: $14,923
Dr. Ralph Crowe, M.d, M.D
Family Medicine — Payments: $14,896